Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023, 2024.
Financials
Financial year 2025
PHARMACIEN BIOLOGISTE CAROLINE DEBECKER from Seneffe, company number BE0820592383, closed financial year 2025 with a result of € 95,939 after tax. For that financial year PHARMACIEN BIOLOGISTE CAROLINE DEBECKER recorded a gross margin of € 147,862 and equity of € 474,382. Compared with financial year 2024, the result moved from € 88,971 to € 95,939. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 474,382
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 95,939
▲ 8% vs 2024
Profit after tax over the fiscal year.
€ 532,796
▼ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 88,618 paid out
92 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 1,242
▼ 47% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 108,977
▼ 10% vs 2024
€ 12,428 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 3,826
▼ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 14,025
▼ 73% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 128,550 | € 146,835 | € 140,839 | € 147,862 | ▲ 5% |
| Profit after taxes | € 76,915 | € 88,101 | € 88,971 | € 95,939 | ▲ 8% |
| Equity | € 453,116 | € 464,384 | € 467,060 | € 474,382 | ▲ 2% |
| Total debts | € 234,744 | € 251,394 | € 261,980 | € 211,015 | ▼ 19% |
| Cash | € 548,847 | € 563,818 | € 565,144 | € 532,796 | ▼ 6% |
| Land & buildings | € 124,617 | € 115,724 | € 106,928 | € 98,454 | ▼ 8% |
| Retained profit | € 446,916 | € 458,184 | € 460,860 | € 468,182 | ▲ 2% |
| Dividend | € 52,737 | € 76,833 | € 86,294 | € 88,618 | ▲ 3% |
| Bank debt | € 145,192 | € 133,664 | € 121,344 | € 108,977 | ▼ 10% |
| Balance sheet total | € 687,860 | € 715,778 | € 729,040 | € 685,396 | ▼ 6% |
Key figures of PHARMACIEN BIOLOGISTE CAROLINE DEBECKER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIEN BIOLOGISTE CAROLINE DEBECKER?
What happened at PHARMACIEN BIOLOGISTE CAROLINE DEBECKER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 95,939 (▲ 8% vs 2024). filed late Source: NBB ↗
- New establishment in Pont-à-Celles. KBO
- Start of the company according to the CBE. KBO
In short
From € 76,915 profit in 2022 to € 95,939 profit in 2025.
Paid € 146,103 in corporate taxes since 2022.
Best year ever: 2025, with € 95,939 profit.
Paid out € 304,482 in dividends to the owners in total.
A new publication or filing at PHARMACIEN BIOLOGISTE CAROLINE DEBECKER? We notify you, reason included.
Follow PHARMACIEN BIOLOGISTE CAROLINE DEBECKERDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIEN BIOLOGISTE CAROLINE DEBECKER is Caroline DEBECKER.
Directors
According to the 2025 annual accounts
Caroline DEBECKER
Director
Establishments
Establishment units
Physical locations of this company
Avenue Nouvelle 36
7180 Seneffe
Rue Paul Pastur(BUZ) 14
6230 Pont-à-Celles
Active since 28 December 2009
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0820.592.383
- VAT number
- BE 0820.592.383
- Registered office
- Avenue Nouvelle 36, 7180 Seneffe
- Names & denominations
- PHARMACIEN BIOLOGISTE CAROLINE DEBECKER · PHARMABIO DEBECKER
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 November 2009
- Peppol
- Active · Active since 17 Mar 2026
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.